Improve Ion Exchange Methods with Faster Method Development and Lower Dispersion
September 21st 2021Tuesday, September 21, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Want faster method development? Better ion exchange methods? Lower dispersion? Learn the latest techniques and innovations to optimize your applications and workflows.
Vector in HyPerforma Single-Use Bioreactors (S.U.B.s) using ExpiSf Expression System
September 16th 2021Thursday, September 16, 2021at 11am EDT| 8am PDT| 4pm BST| 5pm CEST Thermo Scientific HyPerforma Single Use Bioreactors (S.U.B.s) are widely used in the biopharma industry and can be used for a broad range of processes. With the rapid growth of the viral vector gene therapy industry, having a trusted partner is crucial to the success of scaling these processes. This webinar focuses on the scalability of both the HyPerforma 5:1 S.U.B. and the HyPeforma DynaDrive S.U.B. for growth and transfection of ExpiSf insect cells for adeno-associated virus vector production.
Technology Forum: The Next Steps for Pharma Manufacturing Efficiency and Effectiveness
September 15th 2021Wednesday, September 15, 2021 at 10am EDTDrug manufacturing demands and increased regulatory oversight are prompting pharmaceutical manufacturers to consider new processes for oral solid dose and aseptically processed drugs. A cross-section of industry experts will offer insight on emerging trends, technologies, and processes in this Technology Forum.
The Next Generation of Software Validation: Self-Validating Software
September 9th 2021Thursday September 9, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST Is computer software validation (CSV) holding you back from adopting the latest technology. Join this webinar for a look at the future of software validation and how it will remove the documentation burdens.
Method Robustness and Transferability for Modern Size-Exclusion Methods
August 26th 2021Thursday, August 26, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Developing a robust, transferable size-exclusion chromatography (SEC) method for routine testing of mabs and other biotherapeutics can be challenging. Join us for this presentation to learn about SEC method development, with an emphasis on method transfer and sustainability.
Analysis of Viral Proteins, Nucleic Acids and Biomolecular Interactions with Light Scattering
August 17th 2021Tuesday, August 17, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST Characterizing viral proteins and their interactions is key to understanding of how a virus infects cells and for the development of protein-based drugs. Learn how light scattering technology can be used for the biophysical characterization of viral proteins, mAbs, and their interactions.
Gene Therapy Manufacturing: A Dual Platform Reconciling Adherence and Suspension Approaches
July 15th 2021Thursday, July 15, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST What adherence and suspension-based technologies are best for gene therapy production? In this webinar, learn about a next-generation dual platform solution for viral vector manufacturing that helps to overcome existing barriers to scaling and commercializing gene therapies.
Dive Into Summer's Latest Innovations and Best Practices for Biopharma
July 13th 2021Tuesday, July 13, 2021 at 10am EDT | 3pm BST | 4pm CEST Biopharmaceuticals or biologics are a diverse class of compounds that need special attention from discovery, CQAs analysis, manufacturing and QC. Liquid Chromatography is an essential tool for structure characterization, PTM, glycan analysis and quality control of biopharmaceuticals. In this webinar, speakers will discuss the current challenges analytical laboratories face when manufacturing or analyzing biologics and how the hurdles of compromised sample integrity, process analytical integration, and surface interaction may be overcome. Whether analyzing large biomolecules, mAbs, intact proteins, oligonucleotides, aggregates, charge variants, ADCs, peptides, glycans or spent media, there is something for everyone.
Why Flexible End-to-End Solutions Succeed in BDS Handling
May 27th 2021*Thursday, May 27, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST* Transportation of your bulk drug substance (BDS) from downstream to the fill/finish site might not be as simple as it sounds. Mostly geographically detached, each batch of BDS is filled into different primary packaging, frozen to sub-zero temperatures, stored, and shipped before it is then thawed and drained at the fill/finish site. *On Demand Until May 27, 2022*
Bridging the Digital Divide to Advance Bio/Pharma Manufacturing and Quality: A Technology Forum
May 25th 2021*Tuesday, May 25, 2021 at 10am EDT* The bio/pharma industry is turning to proven digital technologies used in other industries to plan, develop, and monitor manufacturing processes, as well as in quality, training, and regulatory oversight. In this event, experts discuss how artificial intelligence, remote monitoring, digital twins, and other technologies can be applied to modernize bio/pharma processes and systems. Lessons learned from the pandemic will be shared. *On Demand Until May 25, 2022*
Method Development Strategies for Purity Analysis of Proteins by Intact and Subunit Analysis
May 24th 2021***Live: Monday, May 24, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST *** Join us to learn best practices in method development for intact and subunit purity analysis for mAbs by reversed-phase liquid chromatography (RPLC), including how to best adjust method parameters such as temperature, gradient slope, and flow rate to obtain high-quality impurity profiling and ensure method robustness and reproducibility. ***On Demand until May 24, 2022***
LC-MS Analysis of Adeno-Associated Virus Critical Quality Attributes
May 11th 2021*Tuesday, May 11, 2021 at 9am EDT | 2pm BST | 3pm CEST, Tuesday, May 11, 2021 at 2pm EDT | 1pm CDT | 11am PDT* Adeno-associated viruses (AAVs) are an important tool enabling the delivery of next-generation gene therapies. *Available On Demand Until May 11, 2022*
Using AI for CAPA and Root-Cause Investigations
May 6th 2021*Thursday, May 6, 2021 at 2pm EDT | 1pm CDT | 11am PDT* Learn how artificial intelligence can be used to investigate corrective and preventive actions, pinpoint the root cause of the most common complaints, tell if training is effective, and identify the combination of materials and workers to increase production. *On Demand Until May 6, 2022*
Bioprocess Cleaning Best Practices: Raw Materials vs. Blended Detergents
April 27th 2021***Live: Tuesday, April 27, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST** This webcast will intensively discuss differences between cleaning using commodity chemicals and blended detergents. Real-life examples—including discussion on cleaning of fermentation residues and processing aids—will illustrate cleaning challenges in the biotechnology industry. *On Demand until April 27, 2022*
Ultra-fast Analysis of Intact Proteins and Oligonucleotides Using High-Throughput Mass Spectrometry
April 26th 2021***Live: Monday, April 26, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST *** Analytical characterization of biomolecules can be challenging because impurities from the synthesis, expression, and degradation of the intended product make the samples complex. Discover the latest innovations, using high-throughput mass spectrometry, to streamline workflows, and simplify complicated analysis, increase throughput, and accelerate bringing biomolecules to market.***On Demand until Apr. 26, 2022***
Technology Forum Series: Strategies to Prevent Drug Shortages and Resolve Capacity Challenges.
***Session 1: Thursday, April 22, 2021, 10am EDT, Session 2: Thursday, April 22, 2021, 11am EDT, Session 3: Thursday, April 22, 2021, 1pm EDT*** A drug’s journey from development to manufacturing to patients is paved with roadblocks and potholes; many threats can derail bio/pharmaceutical processes. Potential solutions to such pitfalls have been discussed for years; however, few manufacturers have embraced technology and process advances to proactively ensure drug supply chain continuity.
Designing Stability Programs for Drug Substances and Products
April 13th 2021***Live Tuesday, April 13, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST** Designing a successful stability program can go a long way towards getting your drug product or substance to market. Join this webinar to receive guidance on designing stability testing programs and overcoming potential challenges. *On Demand until April 13, 2022*
Profiling the HLA-II Immunopeptidome of SARS-CoV-2 Spike Glycoprotein Using Mass Spectrometry.
March 30th 2021***Available Now!*** In this webinar, Mike Knierman, Eli Lilly, will discuss the use of mass spectrometry to identify unique sequences from SARS-CoV-2 spike glycoprotein extracellular domain in a complex with human leukocyte antigen class II molecules on antigen presenting cells from healthy donors. This work exemplifies the value-add of mass spectrometry in vaccine development. *On Demand until March 30, 2022*
Leveraging the Power of a Core-Shell LC Particle to Improve Micro and Nano Flow Separations
March 29th 2021***Live: Monday, March 29, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST *** In order to achieve the required sensitivity when working with small samples sizes, such as in the case of proteomic or metabolomic analysis, a low flow rate LC column is required. Micro and nano LC provides a practical solution for labs and along with the added advantage of core-shell particles, the sensitivity needs are exceeded. ***On Demand until Mar. 29, 2022***
Hydrogen–Deuterium Exchange Coupled with Cyclic Ion Mobility for Higher Quality Analyses
March 25th 2021*Thursday, March 25, 2021 at 10am EDT| 7am PDT| 2pm GMT| 3pm CET* Join us to learn how to address challenges with screening protein complexes using hydrogen–deuterium exchange and cyclic ion-mobility MS. *On demand available after final airing until March 25, 2022*